Furthermore, a mass spectrometry-based phosphoproteomic study comparing aggressive PCa cell lines, namely PC-3 and PC-3M, revealed that PAK2 was upregulated in highly metastatic cells, with its phosphorylation linked to enhanced tumor migration [62]. This evidence concerns the gene PAK2 and neoplasm.